Fracture during oral bisphosphonate therapy is associated with deteriorated bone material strength index

Patients who fracture while receiving BPs treatment have worse BMSi scores than BP-treated patients without fractures. The potential for BMSi to provide an additional osteoporosis treatment target should be explored.